adaptive(US) | $7,000,000 | (Apr 23, 2025)
Tally(US) | $8,000,000 | (Apr 23, 2025)
Recce | $4,000,000 | (Apr 23, 2025)
Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
UbiQD, Inc. | $20,000,000 | (Apr 23, 2025)
Arch Network | $13,000,000 | (Apr 23, 2025)
GreenFi | $17,000,000 | (Apr 23, 2025)
Hopper Security | $7,600,000 | (Apr 23, 2025)
Capably | $4,000,000 | (Apr 23, 2025)
Puresport | $4,788,090 | (Apr 23, 2025)
Reusables.com | $2,600,000 | (Apr 23, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)